This website uses cookies to enhance the user experience.
STANDARD BIO AS

STANDARD BIO AS996 515 427

Research
Limited company
Televegen 2 3802 BØ I TELEMARK, Norge

STANDARD BIO AS

Standard Bio

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Links

Organization

Chairman of the board
Years since formation
14 years
since Feb 3, 2011
Type
Limited company
VAT registered
Yes
Number of employees
9

Ownership

Number of shares and share classes
17,375,012
2 share classes
Total number of shareholders
158
55 companies, 103 persons
Belongs to group of

Financials

Total operating income 2023
25,114,069
NOK
Annual total result 2023
-2,593,977
NOK
Total equity 2023
20,071,869
NOK
Last update: Nov 13, 2024

Management

Management / administration

NameRoleShares
Managing Director/CEO
2.3 %
directly

Board

NameRoleShares
Chairman
9.34 %
indirectly
Board Member-
Board Member-
Board Member
2.63 %
indirectly

Others

NameRoleShares
Auditor-
S
STATEMENT AS
Accountant-

Top 10 individual shareholders

NameRoleShares
Chairman
9.34 %
indirectly
-
6.01 %
indirectly
-
3.21 %
indirectly
Board Member
2.63 %
indirectly
Managing Director/CEO
2.3 %
directly
-
1.65 %
indirectly
-
1.48 %
indirectly
-
1.37 %
indirectly
-
1.32 %
indirectly
-
1.16 %
directly 1.13 %
indirectly 0.02 %
Last update: Apr 13, 2023

Ownership

Company shareholders

NameShare classNumber of sharesShare
A-shares
3,237,098
18.63 %
C
COMMERCOR AS
Preference shares
1,924,280
11.07 %
C
COMMERCOR AS
A-shares
1,613,813
9.29 %
S
SUMMEN VENTURE AS
A-shares
1,186,836
6.83 %
A-shares
976,775
5.62 %
B
BAGGINS VENTURE AS
A-shares
975,877
5.62 %
C
CLAWBACK AS
A-shares
878,434
5.06 %
B
BAGGINS AS
Preference shares
658,733
3.79 %
S
SUMMEN AS
Preference shares
639,359
3.68 %
Preference shares
628,612
3.62 %
C
CAPTUREBANK HOLDING AS
A-shares
488,996
2.81 %
M
MARCHFIRST NORWAY AS
A-shares
428,819
2.47 %
S
SKALTOR AS
A-shares
414,384
2.38 %
A-shares
400,459
2.3 %
V
VALTOR AS
A-shares
324,064
1.87 %
F
FAMARA HOLDING AS
A-shares
257,661
1.48 %
C
CHRISNIC CAPITAL AS
A-shares
212,302
1.22 %
H
HUITFELDT-KAAS AS
A-shares
200,000
1.15 %
K
KRAKR AS
A-shares
199,816
1.15 %
A-shares
196,912
1.13 %
A-shares
167,363
0.96 %
A-shares
112,857
0.65 %
A-shares
112,099
0.65 %
A-shares
111,773
0.64 %
A
ACCRUITY AS
A-shares
102,334
0.59 %
M
MAHA NORGE AS
A-shares
93,588
0.54 %
T
A-shares
76,857
0.44 %
C
CENTAURUS AS
A-shares
61,538
0.35 %
O
OVE LERDAHL AS
A-shares
57,318
0.33 %
S
SCAN-AMERICAN TRADING CO AS
A-shares
54,793
0.32 %
A-shares
54,636
0.31 %
G
GRÜNDERSEN AS
A-shares
53,793
0.31 %
A-shares
46,365
0.27 %
A-shares
46,365
0.27 %
A-shares
46,365
0.27 %
A-shares
42,944
0.25 %
S
SMÅSTØLANE AS
A-shares
26,613
0.15 %
A
ALYLA AS
A-shares
25,353
0.15 %
M
MAFELA AS
A-shares
22,838
0.13 %
A-shares
21,981
0.13 %
T
TJELD AS
A-shares
19,327
0.11 %
A-shares
13,747
0.08 %
F
FIRST PARTNERS HOLDING 8 AS
A-shares
13,396
0.08 %
I
IMOVEST AS
A-shares
13,106
0.08 %
A-shares
12,000
0.07 %
A-shares
11,927
0.07 %
B
BENARES AS
A-shares
9,964
0.06 %
H
HURD AS
A-shares
9,557
0.06 %
A-shares
8,400
0.05 %
U
UTGARD AS
A-shares
7,782
0.04 %
A-shares
6,440
0.04 %
S
SARAFINA AS
A-shares
4,937
0.03 %
A
AKROBAT INVEST AS
A-shares
4,868
0.03 %
A-shares
4,636
0.03 %
A-shares
4,636
0.03 %
D
DIN MENTOR AS
A-shares
4,000
0.02 %
A-shares
3,653
0.02 %
A-shares
3,600
0.02 %
A-shares
3,017
0.02 %
A-shares
3,000
0.02 %
S
STANDARD BIO AS
A-shares
2,737
0.02 %
M
MUTLE AS
A-shares
2,595
< 0.01 %
L
LANGEFINNE AS
A-shares
2,594
< 0.01 %
S
STOKNES FUTURES AS
A-shares
2,142
< 0.01 %
M
MOLDBAKKEN AS
A-shares
1,994
< 0.01 %
T
THEMAR EIENDOM AS
A-shares
1,340
< 0.01 %
A-shares
1,334
< 0.01 %
C
CORTON AS
A-shares
1,250
< 0.01 %
A-shares
1,244
< 0.01 %
A-shares
1,142
< 0.01 %
A-shares
1,035
< 0.01 %
A-shares
999
< 0.01 %
A-shares
730
< 0.01 %
A-shares
702
< 0.01 %
A-shares
557
< 0.01 %
A-shares
533
< 0.01 %
A-shares
525
< 0.01 %
A-shares
499
< 0.01 %
A-shares
486
< 0.01 %
A-shares
445
< 0.01 %
A-shares
434
< 0.01 %
A-shares
387
< 0.01 %
A-shares
360
< 0.01 %
A-shares
347
< 0.01 %
H
HBT SUPPORT AS
A-shares
336
< 0.01 %
A-shares
317
< 0.01 %
A-shares
289
< 0.01 %
F
FJORD-PARTNERS AS
A-shares
272
< 0.01 %
A-shares
227
< 0.01 %
A-shares
217
< 0.01 %
A-shares
157
< 0.01 %
A-shares
157
< 0.01 %
A-shares
157
< 0.01 %
A-shares
146
< 0.01 %
A-shares
135
< 0.01 %
A-shares
131
< 0.01 %
A-shares
130
< 0.01 %
A-shares
127
< 0.01 %
B
BLÅKAMPEN HOLDING AS
A-shares
123
< 0.01 %
A-shares
119
< 0.01 %

Shares owned by the STANDARD BIO AS

NameShare classNumber of sharesShare
D
DRYSEP AS
Ordinary shares
1,000,000
100 %
B
BIONÉR AS
Ordinary shares
2,110,000
100 %
U
UPCYCLE TECHNOLOGIES AS
Ordinary shares
30,000
100 %
E
ERA BIOCARBON AS
Ordinary shares
30,000
100 %
G
GAMKINN BIO AS
Ordinary shares
12,000
40 %
S
STANDARD BIO AS
A-shares
2,737
0.02 %
Last update: May 24, 2024

Group structure

  • Total operating income 2023: NOK 25,114,069
    Operating profit 2023: NOK -893,856
    Employees: 9

Financials

in NOK

Summary

Year202320222021
Total operating income
25,114,069
8,012,262
6,775,948
Annual Total Result
-2,593,977
-7,427,038
-9,253,171
Total assets
39,160,932
25,170,613
37,923,688
Total liabilities
19,089,063
22,914,986
38,241,019
Total equity
20,071,869
2,255,627
-317,331

P&L

Year202320222021
Total operating income
25,114,069
8,012,262
6,775,948
Total operating costs
26,007,925
14,577,381
14,968,037
Operating result
-893,856
-6,565,119
-8,192,089
Financial income/costs
-1,700,121
-861,919
-1,061,082
Profit before tax
-2,593,977
-7,427,038
-9,253,171
Total tax & extraordinary income/cost
0
0
0
Annual Total Result
-2,593,977
-7,427,038
-9,253,171

Balance overview

Year202320222021
Total fixed assets
33,469,409
24,114,583
21,810,360
Total current assets
5,691,523
1,056,030
16,113,327
Total assets
39,160,932
25,170,613
37,923,688
Short term debt
13,358,428
16,230,371
30,578,872
Long term debt
5,730,635
6,684,615
7,662,147
Total liabilities
19,089,063
22,914,986
38,241,019
Contributed capital
20,071,869
13,521,673
21,610,672
Retained earnings
0
-11,266,046
-21,928,003
Total equity
20,071,869
2,255,627
-317,331
Total equity and liabilities
39,160,932
25,170,613
37,923,688

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology